Cyclerion Therapeutics
CYCN
CYCN
34 hedge funds and large institutions have $8.95M invested in Cyclerion Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
55% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 11
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
34
Holding in Top 10
–
Calls
$148K
Puts
$1K
Top Buyers
| 1 | +$127K | |
| 2 | +$11.3K | |
| 3 | +$4.34K | |
| 4 |
Morgan Stanley
New York
|
+$3.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.39K |
Top Sellers
| 1 | -$42.5K | |
| 2 | -$32K | |
| 3 | -$19.4K | |
| 4 |
Jane Street
New York
|
-$16.7K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.3K |